Table 2.
Serum levels of 6 protein biomarkers from the first group of participants
| Levels of proteins, cps | Controls | T1D | T2D | P (T1D vs controls) | P (T2D vs controls) | P (T1D vs T2D) |
|---|---|---|---|---|---|---|
| OPN | 106 ± 32 (× 102) | 235 ± 135 (× 102) | 134 ± 81 (× 102) | 9.382E-7 | .66 | 1.577E-7 |
| IL-1RA | 3071 ± 2668 | 271 ± 269 | 612 ± 570 | 1.997E-12 | .003 | 3.362E-9 |
| YKL-40 | 1299 ± 639 (× 102) | 308 ± 139 (× 102) | 283 ± 75 (× 102) | 4.439E-29 | 5.677E-18 | .81 |
| M-CSF | 59 ± 30 | 20 ± 9 | 17 ± 8 | 3.104E-4 | 3.872E-4 | .10 |
| TRAIL | 82 ± 38 | 151 ± 44 | 142 ± 36 | 4.461E-45 | 6.132E-31 | .89 |
| SAA | 3372 ± 2436 (× 104) | 803 ± 3726 (× 104) | 1083 ± 3841 (× 104) | 1.133E-25 | 1.846E-18 | .04 |
Abbreviations: cps, counts per second; IL-1RA, interleukin 1 receptor antagonist; M-CSF, macrophage colony-stimulating factor 1; OPN, osteopontin; SAA, serum amyloid A1; T1D, type 1 diabetes; T2D, type 2 diabetes; TRAIL, tumor necrosis factor superfamily member 10; YKL-40, chitinase 3-like 1.